 |
인쇄하기
취소
|
Facility investment remains strong
Investment of Korean drug manufacturers in facilities last year grew sharply due to more toughened GMP rating screening, the Korea Food and Drug Administration said recently.
58 Korean drugmakers spent an average of 5.0 billion won in 2006 on improving or expanding their facilities, totaling 325.0 billion, according to the KFDA. In 2005, the spending amounted to 164.9 billion won.
The GMP...
58 Korean drugmakers spent an average of 5.0 billion won in 2006 on improving or expanding their facilities, totaling 325.0 billion, according to the KFDA. In 2005, the spending amounted to 164.9 billion won.
The GMP...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.